- In April 2023, Abbott Laboratories introduced the TactiFlex Ablation Catheter, Sensor Enabled, designed to enhance contact force sensing capabilities during cardiac ablation procedures. The catheter integrates advanced deflection control and real-time feedback, enabling precise lesion creation and improved outcomes in atrial fibrillation treatment. This development highlights Abbott’s continued commitment to innovation in electrophysiology and minimally invasive cardiovascular care
- In March 2023, Boston Scientific Corporation launched the POLARx Cryoablation System with enhanced steerable catheter functionality in selected international markets. Designed for pulmonary vein isolation, this system features improved catheter flexibility and visualization, allowing for more effective navigation in atrial fibrillation cases. The advancement reflects Boston Scientific’s strategic efforts to expand its electrophysiology portfolio and cater to growing global demand for catheter-based ablation therapies
- In March 2023, Biosense Webster, Inc. (a Johnson & Johnson company) announced the successful rollout of its QDOT MICRO Catheter in multiple global markets. The catheter features micro-electrode technology and superior deflection capabilities, offering enhanced mapping precision during complex arrhythmia ablations. This launch demonstrates the company’s focus on technological leadership in high-resolution electrophysiology solutions
- In February 2023, Medtronic plc received expanded regulatory approval for its FlexCath Advance Steerable Sheath to support cryoballoon ablation procedures in additional countries across Europe and Asia. The sheath offers superior torque response and deflectability, allowing physicians greater control during transseptal access and catheter positioning. This development strengthens Medtronic’s position in the interventional cardiology space by supporting procedural efficiency and patient safety
- In January 2023, Baylis Medical, now a part of Boston Scientific, launched its enhanced VersaCross Steerable Access Solution with a focus on safe transseptal puncture and improved procedural workflow. The device features bi-directional deflection and is optimized for electrophysiology and structural heart procedures. This innovation aligns with the global trend toward more integrated, user-friendly catheter solutions in complex cardiovascular interventions
